Well Health reports Q4 adjusted EPS C$0.20 vs. (C$0.07) last year

Reports Q4 revenue C$384.8M vs. C$234.8M last year. Hamed Shahbazi, Chairman and CEO of WELL commented, “2025 was a defining year for WELL. We achieved $1.40 billion in revenue and over $200 million in Adjusted EBITDA while meaningfully improving our margin profile, and we met our guidance on both measures. More importantly, 2025 was the year we crystallized who we are: WELL is building the infrastructure for a healthier Canada. Our clinics deliver care, WELLSTAR powers the digital workflows, HEALWELL applies AI at enterprise scale, and CyberWELL protects the data. With the expansion of our credit facility and the largest acquisition pipeline in our history, we are well positioned to accelerate growth in our highest-return market while unlocking value from our US portfolio. We are also very excited with the progress of our WELLSTAR subsidiary which continues to play a central role in digitally enabling healthcare providers across Canada by delivering a highly integrated, increasingly AI-enabled platform that reduces administrative burden and improves clinical workflows. We believe the market has yet to fully appreciate the value embedded in WELLSTAR, and the planned spin-out is designed to surface that value for our shareholders.”